Your browser doesn't support javascript.
loading
Heterogeneity in elimination efforts could increase the risk of resurgence of lymphatic filariasis in Madagascar.
Rajaonarifara, Elinambinina; Roche, Benjamin; Chesnais, Cedric B; Rabenantoandro, Holivololona; Evans, Michelle; Garchitorena, Andres.
Afiliación
  • Rajaonarifara E; UMR 224 MIVEGEC, Univ. Montpellier, IRD, CNRS, Montpellier, France; NGO Pivot, Ifanadiana, Madagascar; Sciences & Ingénierie, Sorbonne Université, Paris, France. Electronic address: elimanambina@gmail.com.
  • Roche B; UMR 224 MIVEGEC, Univ. Montpellier, IRD, CNRS, Montpellier, France.
  • Chesnais CB; UMI 233, IRD, Univ. Montpellier, INSERM 1175, Montpellier, France.
  • Rabenantoandro H; Service de Lutte contre les Maladies Epidémiques et Négligées - Ministère de la Santé Publique, Antananarivo, Madagascar.
  • Evans M; NGO Pivot, Ifanadiana, Madagascar; Departement of Global Health and Social Medicine, Blavatnik Institute at Harvard Medical School, Boston, MA, USA.
  • Garchitorena A; UMR 224 MIVEGEC, Univ. Montpellier, IRD, CNRS, Montpellier, France; NGO Pivot, Ifanadiana, Madagascar.
Infect Genet Evol ; 120: 105589, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38548211
ABSTRACT

BACKGROUND:

Progress in lymphatic filariasis (LF) elimination is spatially heterogeneous in many endemic countries, which may lead to resurgence in areas that have achieved elimination. Understanding the drivers and consequences of such heterogeneity could help inform strategies to reach global LF elimination goals by 2030. This study assesses whether differences in age-specific compliance with mass drug administration (MDA) could explain LF prevalence patterns in southeastern Madagascar and explores how spatial heterogeneity in prevalence and age-specific MDA compliance may affect the risk of LF resurgence after transmission interruption.

METHODOLOGY:

We used LYMFASIM model with parameters in line with the context of southeastern Madagascar and explored a wide range of scenarios with different MDA compliance for adults and children (40-100%) to estimate the proportion of elimination, non-elimination and resurgence events associated with each scenario. Finally, we evaluated the risk of resurgence associated with different levels of migration (2-6%) from surrounding districts combined with varying levels of LF microfilaria (mf) prevalence (0-24%) during that same study period.

RESULTS:

Differences in MDA compliance between adults and children better explained the observed heterogeneity in LF prevalence for these age groups than differences in exposure alone. The risk of resurgence associated with differences in MDA compliance scenarios ranged from 0 to 19% and was highest when compliance was high for children (e.g. 90%) and low for adults (e.g. 50%). The risk of resurgence associated with migration was generally higher, exceeding 60% risk for all the migration levels explored (2-6% per year) when mf prevalence in the source districts was between 9% and 20%.

CONCLUSION:

Gaps in the implementation of LF elimination programme can increase the risk of resurgence and undermine elimination efforts. In Madagascar, districts that have not attained elimination pose a significant risk for those that have achieved it. More research is needed to help guide LF elimination programme on the optimal strategies for surveillance and control that maximize the chances to sustain elimination and avoid resurgence.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Filariasis Linfática / Erradicación de la Enfermedad / Administración Masiva de Medicamentos Límite: Adolescent / Adult / Animals / Child / Child, preschool / Female / Humans / Male / Middle aged País/Región como asunto: Africa Idioma: En Revista: Infect Genet Evol Asunto de la revista: BIOLOGIA / DOENCAS TRANSMISSIVEIS / GENETICA Año: 2024 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Filariasis Linfática / Erradicación de la Enfermedad / Administración Masiva de Medicamentos Límite: Adolescent / Adult / Animals / Child / Child, preschool / Female / Humans / Male / Middle aged País/Región como asunto: Africa Idioma: En Revista: Infect Genet Evol Asunto de la revista: BIOLOGIA / DOENCAS TRANSMISSIVEIS / GENETICA Año: 2024 Tipo del documento: Article Pais de publicación: Países Bajos